Bluechiip Ltd represents values of innovation, reliability, and sustainability in its corporate philosophy. The company focuses on developing and commercializing advanced tracking solutions using its unique and patented technology. Bluechiip's solution provides a highly reliable, tamper-proof, and cost-effective method for tracking and monitoring critical samples, such as those used in healthcare, research, and logistics industries. With a commitment to continuous improvement and a customer-centric approach, Bluechiip aims to provide exceptional solutions that improve efficiency, reduce errors, and enhance overall operational effectiveness. As a result, Bluechiip Ltd sets itself apart as a leading provider of cutting-edge tracking technology solutions.

Bluechiip Ltd is primarily present in Australia.

Bluechiip Ltd has achieved several significant milestones. The company successfully developed its innovative wireless tracking solution, which combines a unique microchip with a passive RFID tag. Bluechiip's technology aims to revolutionize the storage and monitoring of critical biological samples, such as those used in healthcare and pharmaceutical industries. The company has also formed strategic partnerships with leading organizations in various sectors, including healthcare and biobanking, to showcase the potential of its solution. Bluechiip continues to enhance its product portfolio and expand its market reach, positioning itself as a key player in the field of advanced tracking and monitoring systems.

Bluechiip Ltd is an innovative technology company specializing in advanced tracking solutions. Founded in 2005, Bluechiip has revolutionized the way temperature-sensitive assets are monitored and tracked. The company's breakthrough technology combines both passive RFID and MEMS technologies to provide highly accurate and reliable identification of assets in extreme conditions. Bluechiip's patented product, the Bluechiip Smart, is leading the industry in healthcare, life sciences, and sample tracking. With a strong focus on innovation and continuous improvement, Bluechiip Ltd is committed to delivering cutting-edge tracking solutions to meet the evolving needs of its customers.

The main competitors of Bluechiip Ltd in the market include companies like Zymergen Inc., NanoString Technologies Inc., and Fluidigm Corporation.

Bluechiip Ltd is primarily active in the healthcare and life sciences industries.

The business model of Bluechiip Ltd revolves around providing innovative tracking solutions for various industries. The company specializes in developing and commercializing advanced tracking technologies using its proprietary chip and software platform. Bluechiip's unique microchips enable real-time and robust tracking of valuable assets, such as biological samples, electronic components, and medical devices. By incorporating wireless communication and temperature sensing capabilities, Bluechiip's tracking solutions offer accurate monitoring and improved efficiency in inventory management. The company's technology finds applications in healthcare, pharmaceuticals, cryogenic storage, and logistics sectors, ensuring traceability and enhancing supply chain management. Bluechiip Ltd aims to deliver reliable and secure tracking solutions to facilitate seamless operations and safeguard valuable assets for its clients.

Poměr Bluechiip P/E je -2,97.

Koeficient Bluechiip tržních hodnot je 0,56.

AlleAktien kvalitní skóre pro Bluechiip je 7/10.

očekávané Bluechiip obrat je 6,29 mil. AUD.

očekávané Bluechiip zisk je -1,19 mil. AUD.

Bluechiip Ltd is a leading provider of innovative solutions in the cryo-biology industry. The company specializes in developing sample management systems based on the unique Bluechiip technology to improve efficiency and accuracy in cryo-biology. The Bluechiip technology combines RFID and MEMS technology to identify samples even under extreme conditions of -196 degrees Celsius. It offers various products and solutions tailored to the needs of customers, including a sample management system with automatic sample tracking and real-time data monitoring. Bluechiip also partners with other companies in the cryo-biology industry to expand its product portfolio and develop new applications. The company invests in research and development to improve its product portfolio and develop new technologies. It focuses on markets such as biobanks, research institutions, cell therapy, clinical trials, and bioproduction and supply chain management. The Bluechiip technology provides enhanced data capture, increased security, and more efficient sample management solutions for the cryo-biology industry.

Bluechiip vyplácí dividendu ve výši 0 AUD rozdělenou do výplat během roku.

Dividenda pro Bluechiip momentálně nemůže být vypočítána nebo společnost žádnou dividendu nevyplácí.

ISIN společnosti Bluechiip je AU000000BCT7.

WKN společnosti Bluechiip je A1JFYH.

Ticker společnosti Bluechiip je BCT.AX.

Během posledních 12 měsíců vyplatila společnost Bluechiip dividendu ve výši . To odpovídá dividendovému výnosu přibližně . Pro nadcházejících 12 měsíců se očekává, že Bluechiip vyplatí dividendu ve výši 0 AUD.

Výnos z dividend společnosti Bluechiip aktuálně činí .

Bluechiip vyplácí čtvrtletní dividendu. Ta je distribuována v měsících .

Bluechiip vyplácela v posledních 0 letech každý rok dividendu.

Očekává se, že v následujících 12 měsících budou dividendy ve výši 0 AUD. To odpovídá dividendovému výnosu 0 %.

Bluechiip je přiřazen k sektoru 'Informační technologie'.

Aby ses mohl podílet na poslední dividendě Bluechiip ve výši 0 AUD, zaznamenané 21. 9. 2025, měl jsi mít akcii ve svém portfoliu před ex-dnem 21. 9. 2025.

Poslední dividendy byly vyplaceny dne 21. 9. 2025.

V roce 2024 společností Bluechiip bylo vyplaceno 0 AUD ve formě dividend.

Dividendy společnosti Bluechiip jsou vypláceny v AUD.